Drugmaker Akorn Pays $7.9M For Charging Medicare Prescription Prices For 3 Drugs
BOSTON — Drug maker Akorn Operating Co. LLC on Sept. 9 agreed to pay $7.9 million to settle a false claims complaint alleging that the company continued to charge prescription prices...To view the full article, register now.
Already a subscriber? Click here to view full article